ECHO Program (Knowledge Expansion Program), a partnership between Interfarma’s Board of Regulatory Affairs and Anvisa, have held two workshop sessions to discuss Reliance and Real-World Evidence (RWE) / Real-World Data (RWD).
The Reliance module also counted on the support of Fifarma. The meetings took place on August 17th and 31st. The RWE/RWD sessions had the support of Abracro – Association representing Clinical trials organizations- and were held on September 13rd, 20th and 27th and October 4th.
The objective of these workshop sessions is to assist in the expansion of knowledge of technicians/experts at ANVISA, particularly in more sensitive topics, for good performance and agility in the analyzes carried out by the agency.
ECHO Program began in September 2020 and it has been very well evaluated by Interfarma associates and Coordination of Clinical Research of ANVISA (COPEC).
The first module, held in September 2020, had as its debut theme RBM (Risk Based Monitoring) and featured two virtual meetings. In the second module, held in November 2020, the theme of Quality, Production and Development was approached, and two virtual meetings were held. The third module was held in May and June, with the theme “Optimization of Clinical Development”, which had three meetings.
On average, so far, each of the lectures held had the participation of 50 people, between Anvisa technicians and Interfarma’s member companies. The feedback received highlights the excellent quality of the information presented, the organization of the meetings and the exchange of knowledge between the speakers and the public. All videos of the ECHO Program are available on Interfarma’s YouTube channel.